In a critically ill adult, which DVT prophylaxis is associated with the greatest reduction in mortality risk?

In a critically ill adult, which DVT prophylaxis is associated with the greatest reduction in mortality risk?

• A. Intermittent pneumatic compression
• B. Vitamin K therapy
• C. Mechanical ventilation
• D. Anticoagulation therapy

Answer: (D)

Anticoagulation therapy provides the strongest impact on survival in critically ill patients when preventing venous thromboembolism. In the ICU, pharmacologic prophylaxis with low-dose heparin or LMWH reduces the risk of deep venous thrombosis and pulmonary embolism, and this reduction in fatal embolic events translates into a mortality benefit when there are no active bleeding risks. Mechanical methods like intermittent pneumatic compression lower DVT risk but have less clear evidence for lowering mortality compared with pharmacologic prophylaxis. Vitamin K therapy isn’t used for DVT prevention, and mechanical ventilation addresses respiratory failure, not clot prevention. So, when safe, anticoagulation offers the greatest potential to reduce mortality.

Anticoagulation therapy provides the strongest impact on survival in critically ill patients when preventing venous thromboembolism. In the ICU, pharmacologic prophylaxis with low-dose heparin or LMWH reduces the risk of deep venous thrombosis and pulmonary embolism, and this reduction in fatal embolic events translates into a mortality benefit when there are no active bleeding risks. Mechanical methods like intermittent pneumatic compression lower DVT risk but have less clear evidence for lowering mortality compared with pharmacologic prophylaxis. Vitamin K therapy isn’t used for DVT prevention, and mechanical ventilation addresses respiratory failure, not clot prevention. So, when safe, anticoagulation offers the greatest potential to reduce mortality.